… +IMD) is a combination of two neutralizing monoclonal antibodies that bind nonoverlapping
… Although antibodies against SARS-CoV-2 are detected in seropositive individuals in this …

… of anti-SARS-CoV-2 antibody therapy which can provide … SARS-CoV-2 mAbs are generally
developed from antibodies … the use of mAb combination therapies with reduced mortality, viral …

… Casirivimab/imdevimab (Regen-COV) was one of the promising mAb … antibody combination
vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 …

… This randomized, placebo-controlled trial aimed to determine the overall efficacy and
safety of combination therapy with 2 SARS-CoV-2 neutralizing antibodies—amubarvimab and …

… such as SARS-CoV-2–neutralizing antibodies, have become … the combination of casirivimab
plus imdevimab combination (… Because our patient was not eligible for REGEN-COV or any …

… The 2 antibodies in the REGEN-COV cocktail, casirivimab … Toxicology studies for REGEN-COV
were designed to support … Single antibodies and the combination were tested through …

… The development of monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 offers one
such promising approach for COVID-19 prevention and treatment. These mAbs may have an …

… 10/4206 (0.2%) of those who received REGEN-COV at the authorized dose or a higher
dose [5]… The presence of certain substitutions or combinations of substitutions in the SARS-CoV-2 …

… In order to understand whether the antibodies isolated in our study could be combined
together as well as with several published nAbs to form cocktails, we proceeded to compare the …

… REGEN-COV antibody combination and outcomes in outpatients with Covid-19. N Engl J
Med 2021;385(23):e81; doi: 10.1056/NEJMoa2108163 Crossref, Medline, Google Scholar …